Metabolic Effects of Sotagliflozin on Blood Pressure and Body Weight Reduction in People With Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Diabetes and its Complications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Metabolic effects of the dual SGLT 1/2 inhibitor sotagliflozin on blood pressure and body weight reduction in people with diabetes: An updated meta-analysis of randomized controlled trials
J Diabetes Complicat 2022 Nov 04;36(12)108352, J Wu, X Zhao, H Chen, S ZhuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.